Product logins

Find logins to all Clarivate products below.


Therapeutic Botulinum Toxin | Market Insights | Global | 2023

Despite the negative impact of the COVID-19 pandemic, the global market for therapeutic BTX will exhibit rapid growth through 2031. The need to return for maintenance procedures will sustain demand among existing patients, while rising demand driven by expanding indications will fuel procedure volume growth over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, Europe, and Asia Pacific region from 2019 through 2031.

Related Medtech Insights Reports

Report
Therapeutic Botulinum Toxin – Market Insights – Global
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2024
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising…
Report
Spinal Implants | Market Insights | US | 2023
Following the impact of the COVID-19 pandemic, the US spinal implant market will continue to be characterized by strong pressure on device prices. This trend will be mitigated to some extent by…
Report
Interventional Cardiology Devices | Market Insights | US | 2023
The global COVID-19 pandemic has had a negative impact on the IC device market to some extent. The US IC device market is mature and facing intense pricing pressure on established products,…
Report
Peripheral Vascular Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness…